Search Results for "Butrans"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Butrans. Results 1 to 3 of 3 total matches.
See also: buprenorphine
Transdermal Buprenorphine (Butrans) for Chronic Pain
The Medical Letter on Drugs and Therapeutics • Apr 18, 2011 (Issue 1362)
Transdermal Buprenorphine (Butrans) for Chronic Pain ...
The FDA has approved the partial opioid agonist
buprenorphine in a transdermal formulation (Butrans –
Purdue) for treatment of moderate to severe chronic
pain. Buprenorphine has been available in the US for
years in parenteral formulations for pain and in sublingual tablets for opioid dependence.1 Transdermal
buprenorphine has been available in Europe for several
years.2
Buprenorphine Buccal Film (Belbuca) for Chronic Pain
The Medical Letter on Drugs and Therapeutics • Apr 11, 2016 (Issue 1492)
.
Buprenorphine is also available as a transdermal patch
(Butrans) and in a parenteral formulation (Buprenex ...
Belbuca (Endo), a buccal formulation of the partial
opioid agonist buprenorphine, has been approved by the
FDA for management of pain severe enough to require
daily, around-the-clock, long-term opioid treatment.
Buprenorphine is also available as a transdermal patch
(Butrans) and in a parenteral formulation (Buprenex, and
generics) for treatment of pain. A sublingual formulation
of buprenorphine and buccal and sublingual formulations
containing buprenorphine and the opioid antagonist
naloxone are approved for use as alternatives to
methadone for treatment of opioid...
Opioids for Pain
The Medical Letter on Drugs and Therapeutics • Dec 12, 2022 (Issue 1665)
),
and in a transdermal patch (Butrans) for treatment
of pain. In some studies, oral or transdermal buprenorphine ...
A new CDC guideline for prescribing opioids for pain
recently became available. Nonopioid drugs for pain
were reviewed in a previous issue.